Roivant Sciences Ltd.

ROIV ·Healthcare, Drug Manufacturers - General
Financial Statements › SEC Filings

SEC Filings

Form Filed Description
4 Feb 23, 2026 FORM 4
144 Feb 20, 2026
144 Feb 19, 2026
4 Feb 18, 2026 FORM 4
SCHEDULE 13G/A Feb 17, 2026
4 Feb 13, 2026 4
4 Feb 13, 2026 4
4 Feb 13, 2026 4
144 Feb 13, 2026
SCHEDULE 13G/A Feb 13, 2026
4 Feb 11, 2026 FORM 4
SCHEDULE 13G/A Feb 11, 2026
144 Feb 9, 2026
10-Q Feb 6, 2026 10-Q
8-K Feb 6, 2026 8-K
SCHEDULE 13G/A Feb 5, 2026
4 Jan 22, 2026 FORM 4
4 Jan 22, 2026 FORM 4
4 Jan 22, 2026 FORM 4
4 Jan 14, 2026 FORM 4
144 Jan 12, 2026
4 Dec 31, 2025 FORM 4
144 Dec 31, 2025
4 Dec 29, 2025 FORM 4
4 Dec 29, 2025 FORM 4
← Newer Page 6 of 40 · 997 filings Older →